Unknown

Dataset Information

0

Learning from the First Wave of the Pandemic in England, Wales, and Northern Ireland.

ABSTRACT:

SUBMITTER: Pilcher D 

PROVIDER: S-EPMC7924580 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Learning from the First Wave of the Pandemic in England, Wales, and Northern Ireland.

Pilcher David D   Durie Matthew M  

American journal of respiratory and critical care medicine 20210301 5

Similar Datasets

Unknown COVID-19 in critical care: epidemiology of the first epidemic wave across England, Wales and Northern Ireland.
| S-EPMC7545019 | biostudies-literature
Unknown Trends in Intensive Care for Patients with COVID-19 in England, Wales, and Northern Ireland.
| S-EPMC7924583 | biostudies-literature
Unknown Epidemiology of Mycobacterium bovis Disease in Humans in England, Wales, and Northern Ireland, 2002-2014.
| S-EPMC5382737 | biostudies-literature
Unknown Socioeconomic position and subjective oral health: findings for the adult population in England, Wales and Northern Ireland.
| S-EPMC4137102 | biostudies-literature
Unknown Real-world SARS CoV-2 testing in Northern England during the first wave of the COVID-19 pandemic.
| S-EPMC8058098 | biostudies-literature
Unknown Antibiotic resistance among invasive Neisseria meningitidis isolates in England, Wales and Northern Ireland (2010/11 to 2018/19).
| S-EPMC8629238 | biostudies-literature
Unknown Socioeconomic and ethnic inequalities in oral health among children and adolescents living in England, Wales and Northern Ireland.
| S-EPMC6849874 | biostudies-literature
Unknown Delirium identification, prevention and management in intensive care units in England, Wales and Northern Ireland: a survey of practice.
| S-EPMC12747587 | biostudies-literature
Unknown Monitoring the effectiveness of HIV and STI prevention initiatives in England, Wales, and Northern Ireland: where are we now?
| S-EPMC2563811 | biostudies-literature
Unknown Waning of first- and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales.
| S-EPMC9620314 | biostudies-literature